recombinant control insert dna-ptarget plasmid (Promega)

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

Promega recombinant control insert dna-ptarget plasmid
Recombinant Control Insert Dna Ptarget Plasmid, supplied by Promega, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+control+insert+dna-ptarget+plasmid/recombinant+control+insert+dna+ptarget+plasmid/pm37307292-237-20-25
Average 90 stars, based on 1 article reviews

recombinant control insert dna-ptarget plasmid - by Bioz Stars, 2026-11

90/100 stars

Images

Plasmid Preparation:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived ( ) with an average of 83% (Range: 76–92) ( )) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Recombinant:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Control:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Transfection:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Amplification:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Expressing:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Mutagenesis:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Virus:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Derivative Assay:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Clone Assay:

Article Title: Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes.
Article Snippet: .. A plasmid DNA pool of 400 ng, containing 300 ng of the recombinant T/F LTR-pGL3 plasmid and 100 ng of recombinant control insert DNA-pTarget plasmid (Promega Corporation, Madison, WI) for the Tat minus transfection or 100 ng of recombinant HIV-1C consensus (amplified from the following reagent obtained through the NIH HIV Reagent Program, Division of AIDS, NIAID, NIH: Plasmid pcDNA3.1(+) Expressing Isogenic Mutant Human Immunodeficiency Virus Type 1 Subtype C BL43/02 Tat (pC-Tat.BL43.CC), ARP-11785, contributed by Dr. Udaykumar Ranga) or autologous Tat (sequences amplified from the same sample from which the LTR was derived (S1A Fig) with an average of 83% (Range: 76–92) (S1B Fig)) cloned into pTarget plasmid was prepared in 50 μL of serum-free RPMI medium. ..

Review